RhumbLine Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-125,239
| Closed | -$16.5M | – | 4314 |
|
|
2025
Q1 | $16.5M | Sell |
125,239
-405
| -0.3% | -$50.5K | 0.02% | 793 |
|
|
2024
Q4 | $10.5M | Sell |
125,644
-514
| -0.4% | -$42.2K | 0.01% | 1032 |
|
|
2024
Q3 | $9.23M | Buy |
126,158
+962
| +0.8% | +$72.3K | 0.01% | 1104 |
|
|
2024
Q2 | $8.57M | Sell |
125,196
-11,892
| -9% | -$825K | 0.01% | 1107 |
|
|
2024
Q1 | $9.49M | Buy |
137,088
+2,197
| +2% | +$151K | 0.01% | 1072 |
|
|
2023
Q4 | $9.66M | Sell |
134,891
-2,371
| -2% | -$136K | 0.01% | 1077 |
|
|
2023
Q3 | $7.15M | Buy |
137,262
+2,809
| +2% | +$164K | 0.01% | 1155 |
|
|
2023
Q2 | $8.51M | Buy |
134,453
+6,136
| +5% | +$382K | 0.01% | 1089 |
|
|
2023
Q1 | $6.95M | Buy |
128,317
+370
| +0.3% | +$17.9K | 0.01% | 1154 |
|
|
2022
Q4 | $6.77M | Buy |
127,947
+5,919
| +5% | +$297K | 0.01% | 1118 |
|
|
2022
Q3 | $5.68M | Buy |
122,028
+9,742
| +9% | +$509K | 0.01% | 1153 |
|
|
2022
Q2 | $6.41M | Buy |
112,286
+24,404
| +28% | +$1.38M | 0.01% | 1122 |
|
|
2022
Q1 | $5.38M | Buy |
87,882
+11,643
| +15% | +$605K | 0.01% | 1267 |
|
|
2021
Q4 | $3.99M | Sell |
76,239
-957
| -1% | -$40.2K | ﹤0.01% | 1498 |
|
|
2021
Q3 | $2.88M | Buy |
77,196
+3,330
| +5% | +$116K | ﹤0.01% | 1684 |
|
|
2021
Q2 | $3.02M | Sell |
73,866
-20,160
| -21% | -$745K | ﹤0.01% | 1726 |
|
|
2021
Q1 | $3.19M | Sell |
94,026
-7,617
| -7% | -$264K | ﹤0.01% | 1658 |
|
|
2020
Q4 | $3.23M | Buy |
101,643
+12,189
| +14% | +$320K | ﹤0.01% | 1606 |
|
|
2020
Q3 | $2.29M | Sell |
89,454
-11,303
| -11% | -$258K | ﹤0.01% | 1599 |
|
|
2020
Q2 | $2.59M | Buy |
100,757
+18,476
| +22% | +$374K | ﹤0.01% | 1585 |
|
|
2020
Q1 | $1.26M | Buy |
82,281
+13,920
| +20% | +$302K | ﹤0.01% | 1775 |
|
|
2019
Q4 | $2.35M | Buy |
68,361
+1,017
| +2% | +$12.2K | ﹤0.01% | 1711 |
|
|
2019
Q3 | $503K | Buy |
67,344
+3,740
| +6% | +$35.9K | ﹤0.01% | 2322 |
|
|
2019
Q2 | $826K | Buy |
63,604
+3,238
| +5% | +$41.5K | ﹤0.01% | 2142 |
|
|
2019
Q1 | $735K | Sell |
60,366
-506
| -0.8% | -$6.47K | ﹤0.01% | 2163 |
|
|
2018
Q4 | $693K | Buy |
60,872
+18,481
| +44% | +$298K | ﹤0.01% | 2155 |
|
|
2018
Q3 | $920K | Sell |
42,391
-9,205
| -18% | -$192K | ﹤0.01% | 2036 |
|
|
2018
Q2 | $912K | Buy |
51,596
+8,780
| +21% | +$178K | ﹤0.01% | 2044 |
|
|
2018
Q1 | $901K | Sell |
42,816
-371
| -0.9% | -$7.23K | ﹤0.01% | 1990 |
|
|
2017
Q4 | $625K | Sell |
43,187
-489
| -1% | -$7.55K | ﹤0.01% | 2147 |
|
|
2017
Q3 | $689K | Buy |
43,676
+380
| +0.9% | +$5.58K | ﹤0.01% | 2162 |
|
|
2017
Q2 | $538K | Buy |
43,296
+1,455
| +3% | +$16.9K | ﹤0.01% | 2253 |
|
|
2017
Q1 | $680K | Buy |
41,841
+1,445
| +4% | +$20.9K | ﹤0.01% | 2121 |
|
|
2016
Q4 | $610K | Buy |
40,396
+1,908
| +5% | +$26.9K | ﹤0.01% | 2119 |
|
|
2016
Q3 | $587K | Buy |
38,488
+5,207
| +16% | +$211K | ﹤0.01% | 2109 |
|
|
2016
Q2 | $1.29M | Buy |
33,281
+7,098
| +27% | +$255K | ﹤0.01% | 1628 |
|
|
2016
Q1 | $728K | Buy |
26,183
+680
| +3% | +$22.7K | ﹤0.01% | 1988 |
|
|
2015
Q4 | $1.37M | Buy |
25,503
+6,345
| +33% | +$320K | ﹤0.01% | 1602 |
|
|
2015
Q3 | $767K | Buy |
19,158
+703
| +4% | +$22.9K | ﹤0.01% | 1948 |
|
|
2015
Q2 | $590K | Buy |
18,455
+3,500
| +23% | +$88.7K | ﹤0.01% | 2224 |
|
|
2015
Q1 | $357K | Buy |
14,955
+2,800
| +23% | +$62.7K | ﹤0.01% | 2514 |
|
|
2014
Q4 | $215K | Buy |
12,155
+425
| +4% | +$6.64K | ﹤0.01% | 2777 |
|
|
2014
Q3 | $161K | Hold |
11,730
| – | – | ﹤0.01% | 2828 |
|
|
2014
Q2 | $198K | Buy |
+11,730
| New | +$194K | ﹤0.01% | 2844 |
|
Other funds holding ITCI
KIM
HNB